Bio-Vent Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Bio-Vent General Information

Description

Developer of an anti-influenza drug designed to target the viruses responsible for influenza. The company's drug is based on aptamers which are oligonucleotide or peptide molecules that bind to a specific target molecule, enabling healthcare providers to treat their patients and improve their lives.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Tzomet Abba Hillel
  • Yakhin Park
  • Ashkelon 7284
  • Israel
+972
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • Tzomet Abba Hillel
  • Yakhin Park
  • Ashkelon 7284
  • Israel
+972

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bio-Vent Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Aug-2017 Completed Out of Business
1. Early Stage VC 01-Oct-2014 Completed Startup
To view Bio-Vent’s complete valuation and funding history, request access »

Bio-Vent FAQs

  • When was Bio-Vent founded?

    Bio-Vent was founded in 2006.

  • Where is Bio-Vent headquartered?

    Bio-Vent is headquartered in Ashkelon, Israel.

  • What industry is Bio-Vent in?

    Bio-Vent’s primary industry is Drug Discovery.

  • Is Bio-Vent a private or public company?

    Bio-Vent is a Private company.

  • What is Bio-Vent’s current revenue?

    The current revenue for Bio-Vent is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process